Prudence A. Francis
- Oncology top 0.5%
- Cancer Research top 1%
- Pulmonary and Respiratory Medicine top 2%
- Molecular Biology top 10%
- Immunology top 5%
- Co-authors
- Martine PiccartAngelo Di LeoJohn CrownGiuseppe VialeEvandro de AzambujaSherene LoiEmmanuel QuinauxChristos Sotiriou
- Topics
- Breast Cancer Treatment Studies (42 papers)Cancer Treatment and Pharmacology (36 papers)Advanced Breast Cancer Therapies (31 papers)
- Partner nations
- AustraliaUnited StatesSwitzerland
In The Last Decade
Prudence A. Francis
126 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Oncology 3.3k
- Cancer Research 1.5k
- Pulmonary and Respiratory Medicine 1.2k
- Molecular Biology 890
- Immunology 632
Countries citing papers authored by Prudence A. Francis
This map shows the geographic impact of Prudence A. Francis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prudence A. Francis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prudence A. Francis more than expected).
Fields of papers citing papers by Prudence A. Francis
This network shows the impact of papers produced by Prudence A. Francis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prudence A. Francis. The network helps show where Prudence A. Francis may publish in the future.
Co-authorship network of co-authors of Prudence A. Francis
This figure shows the co-authorship network connecting the top 25 collaborators of Prudence A. Francis. A scholar is included among the top collaborators of Prudence A. Francis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prudence A. Francis. Prudence A. Francis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 2 | |
| 5 | 38 | |
| 6 | 27 | |
| 7 | 17 | |
| 8 | 17 | |
| 9 | 1 | |
| 10 | 16 | |
| 11 | 2 | |
| 12 | 83 | |
| 13 | 17 | |
| 14 | 1 | |
| 15 | 17 | |
| 16 | Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98breakdown → | 1213 |
| 17 | 3 | |
| 18 | 138 | |
| 19 | 104 | |
| 20 | Evaluation of an inhibition enzyme immunoassay kit for mammary serum antigen (MSA) | 6 |
About Prudence A. Francis
Prudence A. Francis is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 129 papers that have together received 5.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (42 papers), Cancer Treatment and Pharmacology (36 papers) and Advanced Breast Cancer Therapies (31 papers). The work is most often cited by research in Oncology (3.3k citations), Cancer Research (1.5k citations) and Reproductive Medicine (609 citations). Prudence A. Francis has collaborated with scholars based in Australia, United States and Switzerland. Frequent co-authors include Martine Piccart, Angelo Di Leo, John Crown, Giuseppe Viale, Evandro de Azambuja, Sherene Loi, Emmanuel Quinaux, Christos Sotiriou, Roberto Salgado and Erika Hitre. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.